Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Nov;20(5):688–690. doi: 10.1128/aac.20.5.688

Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.

R H Eng, A Person, C Mangura, H Chmel, M Corrado
PMCID: PMC181775  PMID: 6275783

Abstract

Susceptibility to amphotericin B, miconazole, and ketoconazole was determined for 25 clinical isolates of zygomycetes in yeast nitrogen base broth and human serum. In yeast nitrogen base broth, 7 of 25 isolates were susceptible to an imidazole or amphotericin B. In serum, all were resistant to the imidazoles and inhibited by amphotericin B, the current drug of choice for infections caused by zygomycetes.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson E., Wilson D., Arky R. A. Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy. Ann Intern Med. 1967 Apr;66(4):735–742. doi: 10.7326/0003-4819-66-4-735. [DOI] [PubMed] [Google Scholar]
  2. Aerts F., De Brabander M., van den Bossche H., van Cutsem J., Borgers M. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen. 1980 Feb;23(2):53–67. doi: 10.1111/j.1439-0507.1980.tb02581.x. [DOI] [PubMed] [Google Scholar]
  3. Borgers M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis. 1980 Jul-Aug;2(4):520–534. doi: 10.1093/clinids/2.4.520. [DOI] [PubMed] [Google Scholar]
  4. Eng R. H., Corrado M., Chin E. Susceptibility of Zygomycetes to human serum. Sabouraudia. 1981 Jun;19(2):111–115. doi: 10.1080/00362178185380171. [DOI] [PubMed] [Google Scholar]
  5. Mucormycosis. Ann Intern Med. 1980 Jul;93(1):93–108. doi: 10.7326/0003-4819-93-1-93. [DOI] [PubMed] [Google Scholar]
  6. Symoens J., Moens M., Dom J., Scheijgrond H., Dony J., Schuermans V., Legendre R., Finestine N. An evaluation of two years of clinical experience with ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):674–687. doi: 10.1093/clinids/2.4.674. [DOI] [PubMed] [Google Scholar]
  7. WATSON D. C., NEAME P. B. In vitro activity of amphotericin B on strains of Mucoraceae pathogenic to man. J Lab Clin Med. 1960 Aug;56:251–257. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES